IDEXX Laboratories, Inc. (IDXX) Stock
Healthcare · Diagnostics & Research · Member of S&P 500, NASDAQ 100
IDEXX Laboratories, Inc. (IDXX) closed at USD 529.01 on 2026-10-14, a change of -16.6 % over the past year, with a market capitalization of USD 43.16B.
IDEXX Laboratories, Inc. recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-14 | 529.01 |
| 2026-10-13 | 520.31 |
| 2026-10-12 | 523.94 |
| 2026-10-09 | 518.00 |
| 2026-10-08 | 513.14 |
| 2026-10-07 | 506.67 |
| 2026-10-06 | 515.41 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
IDEXX Laboratories, Inc. key figures
- Previous close
- USD 529.01 (2026-10-14)
- 1-year change
- -16.6 %
- Market cap
- USD 43.16B
- Enterprise value
- USD 44.01B
- P/E ratio (trailing)
- 38.89
- P/E ratio (forward)
- 32.72
- EPS (trailing)
- 14.07
- EPS (forward)
- 16.73
- PEG ratio
- 2.89
- Price to book
- 26.76
- Revenue growth
- 9.7 %
- Earnings growth
- 17.6 %
- Dividend per share (trailing)
- 0.00
- Short ratio
- 3.75
- Employees
- 11,000
- Analyst consensus (third-party)
- buy
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for IDEXX Laboratories, Inc. and compare it with other stocks.
Analyze IDXXAll S&P 500 stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell IDEXX Laboratories, Inc. shares.